Fortress Biotech
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $18,718 | $16,038 | $16,079 | $17,631 |
Gross Profit | 11,606 | 8,694 | 10,639 | 11,876 |
EBITDA | 3,345 | 147,361 | -3,347 | 12,425 |
EBIT | 2,376 | 145,662 | -4,504 | 11,268 |
Net Income | -468 | 110,373 | -3,937 | 5,850 |
Net Change In Cash | 18,718 | 16,038 | 16,079 | 17,631 |
Free Cash Flow | -59,356 | 203,851 | -12,544 | -6,110 |
Cash | 196,576 | 255,841 | 79,381 | 86,218 |
Basic Shares | 37,011 | 38,412 | 35,756 | 33,100 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $63,262 | $57,675 | $84,513 | $75,743 |
Gross Profit | 42,338 | 36,796 | 61,620 | 44,968 |
EBITDA | -20,165 | -104,491 | -135,721 | -193,694 |
EBIT | -24,826 | -108,955 | -141,718 | -203,047 |
Net Income | 6,815 | -45,997 | -60,637 | -86,575 |
Net Change In Cash | 63,262 | 57,675 | 84,513 | 75,743 |
Free Cash Flow | -65,777 | -95,191 | -136,323 | -182,456 |
Cash | 79,381 | 57,263 | 80,927 | 178,266 |
Basic Shares | 35,756 | 20,784 | 8,111 | 5,925 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.08 |
2026-03-31 | $2.82 |
2025-12-31 | -$0.21 |
2025-09-30 | $0.11 |